套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-034348 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, item 5.02 Accession Number: 0000950170-24-023918 Act: 34 Size: 147 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001590144-24-000015 Act: 34 Size: 11 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-024210 Act: 34 Size: 241 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-024109 Act: 34 Size: 138 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023890 Act: 34 Size: 51 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-24-036334 Act: 34 Size: 69 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001708 Act: 34 Size: 86 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001483 Act: 34 Size: 64 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-009805 Size: 5 KB 网页链接